We calculated the tumor-intrinsic signature scores of the urothelial cancer patients from a PD-L1 blockade cohort and the analysis indicated that DDR-related signatures were remarkably up-regulated in immunotherapy responders (Supplementary Figure 5A). The gene discussed is CD274; the disease is neoplasm.